Analyse-Technique.net - Toutes les news de l'analyse technique

Categories


Tags

Catégorie - NOVARTIS

NOVARTIS - 061009,1245,novartis,mouvement,reste,haussiercommuniques 06/10/09 12:45 NOVARTIS : Le mouvement reste haussierCOMMUNIQUES
SYNTHESE Le MACD est positif et supérieur à sa ligne de signal. Cette configuration confirme la bonne orientation du titre. On constate que le potentiel de hausse du RSI n'est pas épuisé. Les stochastiques ne sont pas surachetés, ce qui laisse intact le potentiel de hausse à moyen terme.
2009-10-06 - TF1

NOVARTIS - empirical,typology,of,bipolar,i,mood,episodes Empirical typology of bipolar I mood episodes *
... Wyeth-Ayerst Laboratories, and Merck; as consultant to Solvay Pharmaceuticals, Shire and Novartis; and on the lecture bureaux of AstraZeneca, Pfizer, ...
2009-11-30 - British Journal of Psychiatry

NOVARTIS - bale,suisse,afp,novartis,va,payer,jusqua,620,m,usd BALE (Suisse) (AFP) - Novartis va payer jusqu'à 620 M USD pour ...
Le groupe pharmaceutique suisse Novartis va acquérir le laboratoire biopharmaceutique américain Corthera pour un montant pouvant aller jusqu'à 620 millions de dollars (434,9 ...
2009-12-23 - La Croix

NOVARTIS - lead,1,ophtalmologie,novartis,rachete,lamericain,alcon LEAD 1 Ophtalmologie - Novartis rachète l'américain Alcon
ZURICH, 4 janvier (Reuters) - Le laboratoire suisse Novartis (NOVN.VX: Cotation ) a annoncé lundi le rachat du groupe américain spécialisé dans les produits ophtalmologiques ...
2010-01-04 - Reuters France

NOVARTIS - bourse,paris,debute,l39annee,hausse,renault,tete La Bourse de Paris débute l'année en hausse, Renault en tête
PARIS (Reuters) - La Bourse de Paris débute l'année sur une note positive, dans la foulée de 2009. La prise de contrôle de Novartis sur l'ophtalmologiste ...
2010-01-04 - nouvelobs.com

NOVARTIS - bourse,paris,debute,lannee,hausse,renault,tete La Bourse de Paris débute l'année en hausse, Renault en tête :
PARIS (Reuters) - La Bourse de Paris débute l'année sur une note positive, dans la foulée de 2009. La prise de contrôle de Novartis sur l'ophtalmologiste américain Alcon soutient le marché.
2010-01-04 - Boursorama

NOVARTIS - novartis,rachete,lamericain,alcon Novartis rachète l'américain Alcon
ZURICH (Reuters) - Le laboratoire suisse Novartis annonce le rachat du groupe américain spécialisé dans les produits ophtalmologiques Alcon pour un coût qui devrait avoisiner ...
2010-01-04 - Reuters France

NOVARTIS - valeur,jour,europe,novartis,leader,lophtalmologie La valeur du jour en Europe - NOVARTIS : leader de l'ophtalmologie
(AOF) - Novartis a franchi une nouvelle étape dans le rachat du numéro un mondial de l'ophtalmologie, l'américain Alcon. Le groupe pharmaceutique suisse, qui cherche à se ...
2010-01-04 - Boursorama

NOVARTIS - alcon,titre,baisse,apres,loffre,novartis Alcon : le titre en baisse après l'offre de Novartis.
(CercleFinance.com) - Les titres Alcon ont ouvert en baisse lundi à la Bourse de New York (NYSE) alors que Novartis propose d'acquérir les 23% du capital du spécialiste de l ...
2010-01-04 - Boursorama

NOVARTIS - novartis,prend,controle,lamericain,alcon Novartis prend le contrôle de l'américain Alcon
Le groupe pharmaceutique suisse a annoncé le rachat d'Alcon, spécialisé dans les produits ophtalmologiques, pour un coût total qui devrait avoisiner 50 milliards de dollars. Le ...
2010-01-04 - L'Expansion

NOVARTIS - alcoa,boeing,chevron,intel Alcoa, Boeing, Chevron, Intel
NSRGY ) and minority shareholders for about $39.3 billion. Nestle will sell a 52% stake to Novartis for an average of $180 a share. Novartis also offered to pay 2.8 of its own shares for each remainin...
2010-01-04 - MalaysiaNews.net

NOVARTIS - acquisition,geante,novartis,ophtalmologie Acquisition géante de Novartis en ophtalmologie
Le laboratoire s'apprête ensuite à lancer une offre publique d'échange sur les 23% d'Alcon encore cotés à la Bourse de New York. Le prix proposé a toutefois ...
2010-01-05 - Le Figaro

NOVARTIS - new,year,brings,two,sweet,deals,for,nestle New Year Brings Two Sweet Deals for Nestlé
For Nestlé, 2010 has already been a very good year. On Jan. 4, the global No. 1 food company sold its 52% stake in eye-care products maker Alcon Inc. to Swiss pharmaceutical group Novartis, for $28 billion. On Jan. 5, Nestlé announced it would acquire the U.S. frozen-pizza business of Kraft Foods ...
2010-01-05 - BusinessWeek

NOVARTIS - comite,direction,independant,d39alcon,repond,novartis Le Comité de direction indépendant d'Alcon répond à Novartis
... règles de fonctionnement de la Bourse de New York) d'un certain nombre de transactions, notamment toute fusion proposée avec un actionnaire majoritaire. ...
2010-01-05 - TF1

NOVARTIS - emerging,mkts,attractive,but,then Emerging mkts attractive, but then...
Hardly had the ink dried on the Pfizer-Wyeth deal, the Swiss drugmaker Novartis has now gone ahead and acquired the remaining stake in Alcon. ...
2010-01-04 - Equitymaster.com

NOVARTIS - nice,appraisal,of,dasatinib,and,nilotinib,for,chronic,myeloid,leukaemia NICE Appraisal Of Dasatinib And Nilotinib For Chronic Myeloid Leukaemia
The National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of dasatinib (made by Bristol Myers-Squibb) and nilotinib (Novartis) for chronic myeloid leukaemia in patients whose treatment with imatinib has failed due to resistance and/or intolerance. As with all NICE appraisals, an independent committee of experts and lay people considered evidence presented ...
2010-01-06 - Medical News Today

NOVARTIS - edf,galp,novartis,sandvik,europe,equity,preview,correct EDF, Galp, Novartis, Sandvik: Europe Equity Preview (Correct)
Vivendi SA (VIV FP): The Paris-based media group is offering to buy 18.1 million shares in Brazilian telecommunications company GVT (Holding SA) at 56 reais ...
2010-01-10 - BusinessWeek

NOVARTIS - nestle,devient,leader,mondial,pizza,surgelee Nestlé devient leader mondial de la pizza surgelée
Le groupe veveysan n’aura pas chômé. Au lendemain de la vente à Novartis du leader des produits ophtalmologiques Alcon, Nestlé a ouvert les emplettes à haut niveau, mais pas ...
2010-01-05 - Tribune de Genève

NOVARTIS - health,canada,approves,novartis,afinitor,to,treat,patients,with,mrcc Health Canada approves Novartis' Afinitor to treat patients with mRCC
Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).
2010-01-20 - News-Medical-Net

NOVARTIS - teva,pharmaceutical,industries,receives,fda,tentative,approval,for,generic,femara,tablets Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis’ breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva’s Letrozole Tablets is expected upon expiry of patent protection for the brand ...
2010-01-22 - News-Medical-Net

NOVARTIS - european,markets,rise,on,us,data,corporate,earnings,european,commentary European Markets Rise On U.S. Data, Corporate Earnings - European Commentary
(RTTNews) - The European markets rose for the first time in five days on Tuesday, as upbeat consumer confidence data from the U.S. and strong earnings report from Siemens and Novartis boosted investor sentiment.
2010-01-26 - INO News

NOVARTIS - novartis,resultats,annuels,2009,superieurs,aux,attentes,nouveau NOVARTIS : résultats annuels 2009 supérieurs aux attentes, nouveau ...
RTFX : Broker sur Devises depuis près de 15 ans RTFX permet aux investisseurs intéressés par le marché des changes de faire du trading de devises en temps réel sur plusieurs ...
2010-01-26 - Capital

NOVARTIS - bayer,settles,with,novartis,over,hemophilia,treatment,patent Bayer Settles With Novartis Over Hemophilia-Treatment Patent
Separately, Novartis sued Wyeth claiming infringement of two patents. Wyeth, now owned by Pfizer Inc., wasn't part of this accord. ...
2010-03-04 - BusinessWeek

NOVARTIS - wall,street,cloture,vert,onzieme,seance,hausse,d Wall Street clôture dans le vert, onzième séance de hausse d ...
1 - Wall Street clôture dans le vert, onzième séance de hausse d'affilée pour le Nasdaq 2 - L'accord avec Novartis fait chuter Transgene 3 - AuFeminin.com ne convainc pas le ...
2010-03-10 - La Tribune

NOVARTIS - bristol,myers,squibb,co,sandoz,penalise,par Bristol-Myers Squibb Co. : Sandoz pénalisé par ...
PARIS (Dow Jones)--Le chiffre d'affaires 2009 de la branche générique de Novartis (NOVN.VX) en France a reculé et la part de marché du groupe y est inférieure à 10%, alors qu ...
2010-03-11 - Investir

NOVARTIS - london,mid,morning,footsie,still,flat London mid-morning: Footsie still flat
LONDON (SHARECAST) - The leading share index is looking for direction, with no major company news from FTSE 100 stocks. Shares in GlaxoSmithKline have moved ahead after rival drug group, Switzerland’s Novartis, had to hand back US rights of a drug widely considered a generic copy of Glaxo's top selling drug, the Asthma treatment Advair.
2010-03-18 - ShareCast

NOVARTIS - eftcom eft.com
Senior supply chain directors from Pfizer, Novartis, Eli Lilly, Myriad Pharmaceuticals, Abbott Laboratories, Purdue Pharma, GE Healthcare, Alcon Laboratories, BSN Medical Devices, Medtronic, Covidien and other top pharmaceutical and medical devices companies will join together for high-level discussions of key supply chain strategies and legislative changes.
2010-03-24 - eyefortransport.com

NOVARTIS - pfizer,novartis,eli,lilly,myriad,pharmaceuticals,abbott,laboratories,purdue,pharmaceutical,discuss,legislative Pfizer, Novartis, Eli Lilly, Myriad Pharmaceuticals, Abbott Laboratories, Purdue Pharmaceutical Discuss Legislative ...
Senior supply chain directors from Pfizer, Novartis, Eli Lilly, Myriad Pharmaceuticals, Abbott Laboratories, Purdue Pharma and other top pharmaceutical companies will join together June 29-30 in Chicago for a high-level discussion of supply chain strategy and legislative changes on the Pharmaceutical Track of the Healthcare & Life Sciences Supply Chain Summit.
2010-03-25 - PharmaceuticalOnline

NOVARTIS - intellipharmaceutics,announces,dismissal,of,patent,litigation,settlement,on,focalin,xr,drug Intellipharmaceutics announces dismissal of patent litigation settlement on Focalin XR drug
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR® ...
2010-05-15 - News-Medical-Net

NOVARTIS - valeur,jour,europe,novartis,tete,smi La valeur du jour en Europe - NOVARTIS en tête du SMI ...
(AOF) - L'action Novartis (+ 3,25% à 55,60 francs suisses) affiche la plus forte progression de l'indice de référence du marché suisse, le SMI. Le titre du groupe ...
2010-06-11 - Boursorama

NOVARTIS - pfizer,joins,brain,disease,coalition Pfizer joins brain-disease coalition
Pfizer Inc. has joined such other major pharmaceutical firms as Abbott, AstraZeneca, Bristol-Myers, Eli Lilly & Co., Novartis and Johnson & Johnson in forming the Coalition Against Major Diseases
2010-06-15 - The Day

NOVARTIS - novartis,myriad,get,boost,after,supreme,court,patent,ruling Novartis, Myriad Get a Boost After Supreme Court Patent Ruling
Myriad Genetics Inc., Genomic Health Inc. and the rest of the burgeoning industry for personalized medicine stand to gain from yesterday’s landmark U.S. Supreme Court decision on patenting business methods.
2010-06-29 - BusinessWeek

NOVARTIS - novartis,myriad,get,boost,after,court,patent,ruling Novartis, Myriad Get Boost After Court Patent Ruling
Myriad Genetics Inc., Genomic Health Inc. and the rest of the burgeoning industry for personalized medicine stand to gain from yesterday’s landmark U.S. Supreme Court decision on patenting business methods.
2010-06-29 - BusinessWeek

NOVARTIS - poxel,raises,eur16,million,in,series,financing,to,accelerate,pipeline Poxel Raises EUR16 million in a Series A Financing to Accelerate Pipeline ...
... pharmaceutical companies established in France, such as sanofi-aventis, GSK, Roche, Novartis, Pfizer, Lilly, Ipsen, Takeda and Boehringer Ingelheim. ...
2010-07-07 - MarketWatch (press release)

NOVARTIS - avila,therapeutics,secures,225m,of,30m,round,announced,last,july,cbl Avila Therapeutics Secures $22.5M of $30M Round Announced Last July - cbl
Waltham-Based Drug Maker Backed by Novartis, Abingworth, Atlas, Polaris By citybizlist Staff WALTHAM...
2010-07-08 - citybizlist Boston

NOVARTIS - novartis,immigration,cisco,tjx,whistleblower,wiseguys,in,court,news Novartis, Immigration, Cisco, TJX, Whistleblower, `Wiseguys' in Court News
Novartis AG’s sales representatives are covered by federal wage-and-hour laws requiring payment of overtime, a U.S. appeals court in New York ruled.
2010-07-07 - Bloomberg

NOVARTIS - novartis,morgan,stanley,passe,surponderer Novartis: Morgan Stanley passe à 'surpondérer'.
(CercleFinance.com) - Morgan Stanley relève sa recommandation sur Novartis de "neutre" à "surpondérer" avec un objectif de cours remonté de 61 à 68 francs suisses ...
2010-07-07 - cercle finance

NOVARTIS - surveyed,neurologists,awareness,of,merck,seronoemd,seronos,oral,cladribine,is,double,that,of,novartismitsubishi Surveyed Neurologists' Awareness of Merck Serono/EMD Serono's Oral Cladribine is Double that of Novartis/Mitsubishi ...
WALTHAM, Mass., July 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed neurologists have low awareness of Novartis/Mitsubishi Tanabe's FTY-720 (Gilenia) among the surveyed oral emerging therapies for the treatment of multiple sclerosis (MS). According to the new report, Brand Perception ...
2010-07-15 - redOrbit

NOVARTIS - amgen,names,peacock,chief,financial,officer Amgen names Peacock chief financial officer
Biotechnology company Amgen Inc. said Thursday it named Novartis executive Jonathan M. Peacock as its new chief financial officer. Peacock succeeds Michael A. Kelly, 53, who has served as acting chief financial officer since May. In April, the company named... Amgen - Chief financial officer - Business - Financial Services - Osteoporosis
2010-07-15 - San Francisco Chronicle

NOVARTIS - amgen,names,novartis,exec,jonathan,peacock,new,cfo Amgen Names Novartis Exec Jonathan Peacock New CFO
Biotechnology giant Amgen, Inc. announced Thursday the appointment of Novartis executive Jonathan Peacock as its new chief financial officer, effective September 1. Peacock will succeed Michael Kelly, who served as acting chief financial officer since May 11, 2010 after Robert Bradway was promoted to president and chief operating officer.
2010-07-15 - RTT News

NOVARTIS - novartis,sues,pto,seeking,extension,of,11,patents Novartis Sues PTO, Seeking Extension of 11 Patents
In January, a three-judge panel of the US Court of Appeals for the Federal Circuit held in Wyeth v. Kappos that the PTO incorrectly calculated patent term ...
2010-07-15 - Corporate Counsel

NOVARTIS - celgene,novartis,sue,sun,pharma,on,para,iv,infringement,of,its,extended,release,adhd,drug,focalin Celgene, Novartis sue Sun Pharma on Para IV infringement of its extended release ADHD drug, Focalin
The US-based Celgene Corporation and the Swiz pharma major Novartis AG have filed a Para IV patent infringement suit against the US subsidiary of the Mumbai-based Sun Pharmaceuticals Industries Ltd with the District Court of New Jersey for allegedly attempting to manufacture and sell the generic version of extended release Focalin, used for the treatment of Attention Deficit Hyperactivity ...
2010-07-14 - PharmaBiz

NOVARTIS - bp,barclays,fiat,novartis,siemens,telefonica,europe,equity,preview BP, Barclays, Fiat, Novartis, Siemens, Telefonica: Europe Equity Preview
The following companies’ shares may have unusual moves in European trading. Stock symbols are in parentheses and prices are from the last close.
2010-07-19 - Bloomberg

NOVARTIS - sanofi,aventis,sanofi,patit,feu,vert,donne SANOFI-AVENTIS : Sanofi pâtit du feu vert donné à un ...
NEW YORK/PARIS, 23 juillet (Reuters) - La première version générique de l'anticoagulant Lovenox de Sanofi-Aventis , développée par le suisse Novartis , a été autorisée ...
2010-07-23 - Investir

NOVARTIS - paris,quasi,stable,resultats,stress,tests,anticipes Paris: quasi stable, résultats stress tests anticipés ...
A Paris, Sanofi Aventis a pesé sur la tendance (-4,25% sur l'autorisation de mise sur le marché d'un générique du Lovenox produit par Novartis), Alcatel-Lucent perd -2,2% dans ...
2010-07-23 - VotreArgent.fr

NOVARTIS - novartis,launches,new,otc,childrens,liquid,acetaminophen,product Novartis launches new OTC children's liquid acetaminophen product
Novartis announces the introduction of Triaminic™ Fever Reducer Pain Reliever, the only branded over-the-counter children's liquid acetaminophen product currently available nationwide in the US. Triaminic® now offers parents a product that combines the pain relieving and fever-reducing power of acetaminophen with the brand that has been trusted by pediatricians and parents for more than 50 years.
2010-07-27 - News-Medical-Net

NOVARTIS - sanofi,aventis,q2,net,up,61,percent Sanofi-Aventis Q2 Net up 61 Percent
Sanofi-Aventis net up 61 percent, warns of hit to earnings from generic challenge to Lovenox Sanofi-Aventis - Food and Drug Administration - Lovenox - Novartis - Generic drug
2010-07-29 - ABC News

NOVARTIS - eni,gdf,infineon,novartis,piaggio,swisscom,european,equity,preview Eni, GDF, Infineon, Novartis, Piaggio, Swisscom: European Equity Preview
The following companies’ shares may have unusual moves in European trading. Stock symbols are in parentheses and prices are from the last close.
2010-08-08 - Bloomberg

NOVARTIS - alcon,inc,switzerland,l39ue,autorise,novartis,racheter Alcon, Inc. (Switzerland) : L'UE autorise Novartis à racheter ...
Investir.fr est un site qui propose aux investisseurs en Bourse et aux internautes la cotation des valeurs en temps réel à Paris un volume de 150 ...
2010-08-09 - Investir.fr

NOVARTIS - eu,clears,novartis,to,buy,us,eye,care,company,alcon EU Clears Novartis To Buy US Eye Care Company Alcon
EU Clears Novartis To Buy US Eye Care Company Alcon
2010-08-09 - FOX Business